Education
About Us
Working with TipRanks
Follow Us
Conmed (CNMD)
NYSE:CNMD
CNMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$46.00 - $78.00
Previous CloseN/A
Volume49.43K
Average Volume (3M)345.31K
Market Cap
$1.50B
Enterprise Value$2.47B
Total Cash (Recent Filing)$33.94M
Total Debt (Recent Filing)$881.83M
Price to Earnings (P/E)13.7
Beta0.49
Next Earnings
Oct 22, 2025EPS Estimate
1.05Last Dividend Ex-Date
Sep 15, 2025Dividend Yield1.65%
Share Statistics
EPS (TTM)1.15
Shares Outstanding30,954,964
10 Day Avg. Volume385,711
30 Day Avg. Volume345,309
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.64
Enterprise Value/Revenue1.86
Enterprise Value/Gross Profit3.31
Enterprise Value/Ebitda10.88
Forecast
1Y Price Target
$63.50Price Target Upside38.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
EarningsCNMD's 1Q25 revenue and EPS exceeded consensus expectations, showcasing strong quarterly performance.
Financial PerformanceGross margin increased by 120 basis points year-over-year, indicating improved cost management.
Bears Say
Debt LevelsCNMD's debt level limits its ability to acquire new growth drivers or repurchase shares, potentially affecting long-term growth.
Product PerformanceAirseal disposables are experiencing a decline in sales for the first time since 2020, raising concerns about CONMED's growth outlook.
Revenue GrowthRevenue growth slowed to 2.9% as supply chain challenges and a decline in Capital Products revenue persisted.
Conmed News
CNMD FAQ
What was Conmed’s price range in the past 12 months?
Conmed lowest stock price was $46.00 and its highest was $78.00 in the past 12 months.
What is Conmed’s market cap?
Conmed’s market cap is $1.50B.
When is Conmed’s upcoming earnings report date?
Conmed’s upcoming earnings report date is Oct 22, 2025 which is in 26 days.
How were Conmed’s earnings last quarter?
Conmed released its earnings results on Jul 30, 2025. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.123 by $0.027.
Is Conmed overvalued?
According to Wall Street analysts Conmed’s price is currently Undervalued.
Does Conmed pay dividends?
Conmed pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 1.65%. See more information on Conmed dividends here
What is Conmed’s EPS estimate?
Conmed’s EPS estimate is 1.05.
How many shares outstanding does Conmed have?
Conmed has 30,954,964 shares outstanding.
What happened to Conmed’s price movement after its last earnings report?
Conmed reported an EPS of $1.15 in its last earnings report, beating expectations of $1.123. Following the earnings report the stock price went up 2.022%.
Which hedge fund is a major shareholder of Conmed?
Currently, no hedge funds are holding shares in CNMD
Conmed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$63.50 (38.07% Upside)
$63.50 (38.07% Upside)
Blogger Sentiment
Bullish
CNMD Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $138.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.50%
12-Months-Change
Fundamentals
Return on Equity
11.69%
Trailing 12-Months
Asset Growth
1.87%
Trailing 12-Months
Company Description
Conmed
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.
CNMD Company Deck
CNMD Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call indicates a positive trajectory with strong revenue and income growth, driven by key products like AirSeal, Buffalo Filter, and BioBrace. However, there are challenges in the orthopedic market share and the impact of tariffs, suggesting a balanced outlook.View all CNMD earnings summariesCNMD Stock 12 Month Forecast
Average Price Target
$63.50
▲(38.07% Upside)
Technical Analysis
Artivion
―
Integra Lifesciences
―
Ufp Technologies
―
AdaptHealth
―
PROCEPT BioRobotics
―
Ownership Overview
0.65% Insiders
41.53% Mutual Funds
1.73% Other Institutional Investors
29.03% Public Companies and
Individual Investors